AcSé-ESMART, a European precision cancer medicine proof-of-concept platform trial.
Geoerger B, Paoletti X, Bautista F, Gatz SA, Marshall LV, André N, Berlanga P, Ducassou S, Pasqualini C, Casanova M, Zwaan CM, Nysom K, Rubino J, Goff DV, Archambaud B, Abbou S, Schleiermacher G, Dufour C, Blanc P, Hoog-Labouret N, Buzyn A, Vassal G.
Geoerger B, et al. Among authors: zwaan cm.
Nat Med. 2023 Dec;29(12):2985-2987. doi: 10.1038/s41591-023-02580-5.
Nat Med. 2023.
PMID: 37857712
No abstract available.